Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
ErleaDx logo — Early Cancer Detection Saves Lives

ErleaDx

Early Cancer Detection Saves Lives

Founded 2021 Singapore Singapore 1 employees Medical Devices

General Information

Company Name ErleaDx
Founded Year 2021
Location Singapore Singapore +1
Employees 1
Industries Medical Devices
Social

Get notified when ErleaDx moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About ErleaDx

ErleaDx is a Singapore-based startup with the mission to develop high-quality diagnostics products for early cancer detection, with a current focus on lung cancer. The company has a patented blood-based biomarker panel that enables the detection of lung cancer with high accuracy at an early stage, allowing for rapid triage and treatment decisions. Emphasizing on Point-Of-Care (POC) diagnostics for lung cancer screening, ErleaDx aims to bring convenience to people by delivering lab-quality results within minutes instead of hours. The company is actively seeking seed investment and welcomes discussions for potential partnerships. With its innovative and integrated device incorporating microfluidic and biosensors expertise, ErleaDx is committed to improving customer satisfaction and patient outcomes, ultimately working towards saving more lives. For inquiries, contact [email protected].

Taxonomy: Early cancer detection, Lung cancer, Diagnostics, Biomedical technology, Point-of-care diagnostics, Biomarker panel, Blood-based diagnostics, Medical devices, Microfluidics, Biosensors, Seed investment, Healthcare innovation, Medical technology, Patient outcomes, Life-saving technology

No funding data available for ErleaDx yet.

Get notified when ErleaDx raises funding

ErleaDx Alternatives & Competitors

ErleaDx vs
Breathonix Pte Ltd
Breathonix Pte Ltd Singapore

Diagnostics Reimagined | Rapid Breath Tests for Disease Detection | Covid-19, Lung Cancer and more

Seed
7 employees
Biotechnology, Health Care
Compare ErleaDx vs Breathonix Pte Ltd
ErleaDx vs
DeepScan Diagnostics
DeepScan Diagnostics Finland

Advancing Pet Health with Early Detection Solutions for a Longer, Healthier Life

12 employees
ErleaDx vs
Craif Inc.
Craif Inc. United States

Harnessing the power of urinary miRNA to detect cancer early

Non Equity Assistance
19 employees
AI, Health Care

FAQ About ErleaDx

Early Cancer Detection Saves Lives
ErleaDx was founded in 2021.
ErleaDx is headquartered in Singapore.
ErleaDx operates in the following industries: Medical Devices.
ErleaDx has approximately 1 employees.
Top alternatives and competitors to ErleaDx include Breathonix Pte Ltd, DeepScan Diagnostics, Craif Inc., Pace Diagnostics, Inc., GeneCast Biotechnology Co., Ltd.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
ErleaDx and Breathonix Pte Ltd are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors ErleaDx and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy